# Essential Pro PMCF Study ( rEPIC04E )

> **NCT05292092** · — · COMPLETED · sponsor: **Fundación EPIC** · enrollment: 161 (actual)

## Conditions studied

- Coronary Artery Disease (CAD)
- Ischemic Heart Disease

## Interventions

- **DRUG:** Essential pro

## Key facts

- **NCT ID:** NCT05292092
- **Lead sponsor:** Fundación EPIC
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-26
- **Primary completion:** 2025-12-29
- **Final completion:** 2026-01-18
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05292092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05292092, "Essential Pro PMCF Study ( rEPIC04E )". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05292092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*